CONTRACEPTIVE RING BIBLIOGRAPHY

1. Barnhart KT, Timbers K, Pretorius ES, Lin K, Shaunik A. In vivo assessment of NuvaRing(R) placement. Contraception. Sep 2005;72(3):196-199.
Link to PubMed

2. Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. Aug 2003;70(8):681-682, 685-686, 668-690 passim.
Link to PubMed

3. Bjarnadottir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol. Mar 2002;186(3):389-395.
Link to PubMed

4. Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. Sep 2002;100(3):585-593.
Link to PubMed

5. Dogterom P, van den Heuvel MW, Thomsen T. Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials. Clin Pharmacokinet. 2005;44(4):429-438.
Link to PubMed

6. Duijkers IJ, Verhoeven CH, Dieben TO, Klipping C. Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle. Hum Reprod. Nov 2004;19(11):2674-2679.
Link to PubMed

7. Freeman S. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling. J Am Acad Nurse Pract. Jun 2004;16(6):226-238.
Link to PubMed

8. Gallo MF, Grimes DA, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2003(1):CD003552.
Link to PubMed

9. Guida M, Di Spiezio Sardo A, Bramante S, et al. Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners. Hum Reprod. Apr 2005;20(4):1100-1106.
Link to PubMed

10. Haring T, Mulders TM. The combined contraceptive ring NuvaRing and spermicide co-medication. Contraception. Apr 2003;67(4):271-272.
Link to PubMed

11. Herndon EJ, Zieman M. New contraceptive options. Am Fam Physician. Feb 15 2004;69(4):853-860.
Link to PubMed

12. Johansson ED, Sitruk-Ware R. New delivery systems in contraception: vaginal rings. Am J Obstet Gynecol. Apr 2004;190(4 Suppl):S54-59.
Link to PubMed

13. Kaunitz AM. Beyond the pill: new data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol. Apr 2005;192(4):998-1004.
Link to PubMed

14. Linn ES. Progress in contraception: new technology. Int J Fertil Womens Med. Jul-Aug 2003;48(4):182-191.
Link to PubMed

15. Massai R, Makarainen L, Kuukankorpi A, Klipping C, Duijkers I, Dieben T. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women. Hum Reprod. Oct 2005;20(10):2764-2768.
Link to PubMed

16. Miller L, Verhoeven CH, Hout JI. Extended Regimens of the Contraceptive Vaginal Ring: A Randomized Trial. Obstet Gynecol. Sep 2005;106(3):473-482.
Link to PubMed

17. Mulders TM, Dieben TO. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril. May 2001;75(5):865-870.
Link to PubMed

18. Mulders TM, Dieben TO, Bennink HJ. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod. Oct 2002;17(10):2594-2599.
Link to PDF

19. Novak A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. Mar 2003;67(3):187-194.
Link to PubMed

20. Oddsson K, Leifels-Fischer B, de Melo NR, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception. Mar 2005;71(3):176-182.
Link to PubMed

21. Oddsson K, Leifels-Fischer B, Wiel-Masson D, et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. Hum Reprod. Feb 2005;20(2):557-562.
Link to PubMed

22. Roumen F. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. Eur J Contracept Reprod Health Care. Dec 2002;7 Suppl 2:19-24; discussion 37-19.
Link to PubMed

23. Roumen FJ, Apter D, Mulders TM, Dieben TO. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod. Mar 2001;16(3):469-475.
Link to PDF

24. Sarkar N. The combined contraceptive vaginal device (NuvaRing(R)): A comprehensive review. Eur J Contracept Reprod Health Care. Jun 2005;10(2):73-78.
Link to PubMed

25. Sivin I, Diaz S, Croxatto HB, et al. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Contraception. Apr 1997;55(4):225-232.
Link to PubMed

26. Sivin I, Mishell DR, Jr., Alvarez F, et al. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception. Feb 2005;71(2):122-129.
Link to PubMed

27. Szarewski A. High acceptability and satisfaction with NuvaRing use. Eur J Contracept Reprod Health Care. Dec 2002;7 Suppl 2:31-36; discussion 37-39.
Link to PubMed

28. van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. Sep 2005;72(3):168-174.
Link to PubMed

29. Veres S, Miller L, Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol. Sep 2004;104(3):555-563.
Link to PubMed

30. Verhoeven CH, Dieben TO. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage. Contraception. Mar 2004;69(3):197-199.
Link to PubMed

31. Westhoff C, Osborne LM, Schafer JE, Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstet Gynecol. Jul 2005;106(1):89-96.
Link to PubMed